Search
for
Sort by
Research 241–270 of 272
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Effect of Dietary Methylsulfonylmethane Supplementation on Growth Performance, Hair Quality, Fecal Microbiota, and Metabolome in Ragdoll Kittens
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Fibroblast growth factors: key players in regeneration and tissue repair
- Receptor activator of NF-κB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit
- Alarmin Cytokines as Central Regulators of Cutaneous Immunity
- SYK inhibitor entospletinib prevents ocular and skin GVHD in mice
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
- Ethnobotanical Survey of Natural Galactagogues Prescribed in Traditional Chinese Medicine Pharmacies in Taiwan
- Mesenchymal Stem Cells Antagonize IFN-Induced Proinflammatory Changes and Growth Inhibition Effects via Wnt/β-Catenin and JAK/STAT Pathway in Human Outer Root Sheath Cells and Hair Follicles
- Endoplasmic reticulum in health and disease: the 12th International Calreticulin Workshop, Delphi, Greece
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
- Modelling Human Hair Follicles—Lessons from Animal Models and Beyond
- Prolactin: A Mammalian Stress Hormone and Its Role in Cutaneous Pathophysiology
- Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata
- The expanding impact of T-regs in the skin
- Cannabinoids and Their Receptors in Skin Diseases
- DKK3–CKAP4 signaling drives fibroimmune remodeling and hair follicle miniaturization in androgenetic alopecia
- Common Skin Diseases and Metabolic Syndrome: A Proinflammatory Chemokine Perspective
- Research Progress on the Immunomodulatory Effects by Dang Gui (Radix Angelica sinensis) and Its Active Chemical Components
- The Intervention Effect of Externally Applying or Orally Administering Bifidobacterium animalis Subsp. lactis J12 on Atopic Dermatitis Induced by 2,4-Dinitrofluorobenzene
- SRD5A2 and emerging therapies in androgen-driven disorders
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Revolutionizing psoriasis care: Microneedle innovations in treatment and diagnosis
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Proceedings of the Ninth World Congress for Hair Research (2015)